Cargando…
EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France, rationale and design of the NAXOS: SNIIRAM study
Non‐vitamin K antagonists oral anticoagulants (NOACs) have recently challenged vitamin‐K antagonists (VKAs) for stroke and systemic embolism prophylaxis in patients with non‐valvular atrial fibrillation (NVAF). Nevertheless, little information is available in routine clinical practice for France. Th...
Autores principales: | Picard, Fabien, Van Ganse, Eric, Ducrocq, Gregory, Danchin, Nicolas, Falissard, Bruno, Hanon, Olivier, Belhassen, Manon, Ginoux, Marine, Lefevre, Cinira, Cotte, François‐Emery, Mahé, Isabelle, Steg, Philippe G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788467/ https://www.ncbi.nlm.nih.gov/pubmed/31313832 http://dx.doi.org/10.1002/clc.23231 |
Ejemplares similares
-
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study
por: Van Ganse, Eric, et al.
Publicado: (2020) -
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
por: Belhassen, Manon, et al.
Publicado: (2022) -
Naxos Disease
por: Protonotarios, Nikos, et al.
Publicado: (2005) -
Ariadne auf Naxos
por: Strauss, Richard, 1864-1949
Publicado: (1988) -
Mr. Okes's New Styptic Powder
por: Okes, Robert John
Publicado: (1807)